Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
24-26 February, 2026
Global ChemShowGlobal ChemShow
Not Confirmed
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Not Confirmed
Not Confirmed
12-15 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 February, 2026
Global ChemShowGlobal ChemShow
Industry Trade Show
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Industry Trade Show
Not Confirmed
12-15 January, 2026
Digital content

07 Dec 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251206866125/en/Zai-Lab-Announces-Updates-to-Chinas-National-Reimbursement-Drug-List

06 Nov 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251106957927/en/Zai-Lab-Announces-Third-Quarter-2025-Financial-Results-and-Recent-Corporate-Updates

31 Oct 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251031556994/en/Zai-Lab-Announces-Participation-in-Investor-Conferences-in-November-and-December-2025

24 Oct 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251024903169/en/Zai-Lab-Announces-Updated-Phase-1-Data-for-Zocilurtatug-Pelitecan-formerly-ZL-1310-Demonstrating-Potential-as-a-First-in-ClassBest-in-Class-DLL3-Targeted-ADC-for-Small-Cell-Lung-Cancer-and-Initiation-of-Global-Phase-3-Registrational-Study

15 Oct 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251015598260/en/Zai-Lab-to-Announce-Third-Quarter-2025-Financial-Results-and-Recent-Corporate-Updates-on-November-6-2025

13 Oct 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251013594159/en/Zai-Lab-Announces-Oral-Presentation-of-Updated-Data-from-Global-Phase-1-Trial-of-Zocilurtatug-Pelitecan-ZL-1310-a-Potential-First-in-Class-DLL3-Targeted-ADC-at-2025-AACR-NCI-EORTC-Conference
ABOUT THIS PAGE